Undisclosed major pharmaco to buy Gamida Cell for significant amount; Novartis is the bidder; terminated
- Drug Discovery Tools
- Gene Therapy, Cell Therapy
- Full Acquisition
- Acquisition of Private Biotech
- Payment Includes Cash
- Includes Earnout
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.